drugset / Trial / NCT01255020

Renal Protective Effects of Restricted Protein Dietary With α-keto Acid in CAPD Patients

NCT01255020 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The prospective, double blind randomized, parallel control, and multi-center clinical trial will evaluate the safety and efficacy of α-keto acid with restricted protein diet on protecting residual renal function in continuous ambulatory peritoneal dialysis (CAPD) patients.

Timeline

Start
2010-03
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator α-Keto Acid Unknown 100 mg/kg —